Tizanidine Tablet
Product Images NDC 63629-3209

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 63629-3209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

A line graph showing plasma tizanidine concentration (ng/mL) over time in hours from dosing. It compares four groups: 2 x 4 mg tizanidine tablets with food, without food, and 2 x 4 mg tizanidine capsules with food and without food. Concentration peaks within a few hours and declines to near zero by 12 to 24 hours post-dose.*

FDA Label Image

Fig2 (Fig2)

A line graph showing improvement in Ashworth Score over 6 hours post-dose for 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The vertical axis measures improvement, while the horizontal axis represents hours after dosing, with 16 mg tizanidine showing the highest improvement peak around 2 hours.*

FDA Label Image

Fig3 (Fig3)

A line graph showing improvement in Ashworth Score over three time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint. It compares tizanidine (mean dose 28.8 mg) and placebo groups, with tizanidine demonstrating greater improvement (lower scores) at all time points. Error bars indicate variability.*

FDA Label Image

Label Image (Lbl636293209)

Tizanidine 2 mg tablet label from Bryant Ranch Prepack, referencing comparison to Zanaflex 2 mg tablet by Dr. Reddy's Laboratories. The label includes storage instructions at 20°-25°C (68°-77°F), a caution about dizziness or drowsiness, a lot number, and an NDC number 63629-3209-1. The tablet is identified as white, oval-shaped.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Tizanidine hydrochloride, showing its molecular structure with a chlorinated benzene ring fused to an imidazole ring and an additional imidazole side chain, corresponding to the active ingredient Tizanidine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.